Private workforces for Amazon SageMaker Ground Truth and Amazon Augmented AI (Amazon A2I) help organizations build proprietary, high-quality datasets while keeping high standards of security and privacy. The AWS Management Console provides a fast and intuitive way to create a private workforce, but many organizations need to automate their infrastructureContinue Reading
Inspecting wind turbines, power lines, 5G towers, and pipelines is a tough job. It’s often dangerous, time-consuming, and prone to human error. That’s why we at Amazon Web Services (AWS) are working on AI Workforce—a system that uses drones and AI to make these inspections safer, faster, and more accurate.Continue Reading
Principal is a global financial company with nearly 20,000 employees passionate about improving the wealth and well-being of people and businesses. In business for 145 years, Principal is helping approximately 64 million customers (as of Q2, 2024) plan, protect, invest, and retire, while working to support the communities where itContinue Reading
Personalization can improve the user experience of shopping, entertainment, and news sites by using our past behavior to recommend the products and content that best match our interests. You can also apply personalization to conversational interactions with an AI-powered assistant. For example, an AI assistant for employee onboarding could useContinue Reading
Aerospace companies face a generational workforce challenge today. With the strong post-COVID recovery, manufacturers are committing to record production rates, requiring the sharing of highly specialized domain knowledge across more workers. At the same time, maintaining the headcount and experience level of the workforce is increasingly challenging, as a generationContinue Reading
John M. Chase/iStock Unreleased via Getty Images Salesforce (NYSE:CRM), a customer relationship management company, reduced its workforce by about 300 positions over the past month, according to a report by Bloomberg. The software firm is reducing roles as it spends more on product innovation, according to people familiar with theContinue Reading
CureVac N.V. (NASDAQ:CVAC) to cut its workforce by 30% as part of a restructuring initiative, as GSK (NYSE:GSK) acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, for €1.45 billion plus royalties. The new agreement extends CureVac’s (CVAC) cash runway into 2028, asContinue Reading
